Review

TTK HEALTHCARE LTD.

Ticker : 507747
FV : ₹ 10 
52-Week H/L : ₹ 870/456.8

We recommended TTK Healthcare Limited in volume no. 38, issue no. 08 (dated December 13, 2021) when the scrip was trading at Rs 770. On a standalone quarterly front, the company recorded an increase of 18.59 per cent in the net sales & operating income, which stood at Rs 212.49 crore for Q3FY22 as compared to Rs 179.19 crore reported for Q3FY21. The operating profit zoomed robustly by 50.45 per cent, standing at Rs 21.58 crore in Q3FY22 as compared to Rs 14.35 crore recorded in Q3FY21. The company reported a net profit of Rs 12.17 crore in Q3FY22 as compared to Rs 7.69 crore recorded in Q3FY21. The stock is currently trading at its highest price as compared to last one month's prices. The stock has outper formed, gaining 2 per cent in the last three months as against a 4 per cent dip in the benchmark index. Hence, we recommend our investor-readers to BOOK PROFIT at Rs 869 per share with a gain of 12.85 per cent.